Abstract
Objective
Insulin-like growth factors (IGF)-I and -II have been implicated in growth and differentiation during embryonic and fetal development. To examine the role of the IGFs ingrowth of the fetal heart, we determined the gene expression of IGF-I and IGF-II in the four cardiac chambers of the ovine fetus from 58 to 146 days’ gestation (term = 147 days).
Methods
Total RNA was obtained from the cardiac chambers, analyzed by Northern blot, and hybridized to ovine specific cDNA probes for IGF-I and IGF-II. The resulting autoradiograms were subjected to light densitometry, and the intensity of the IGF signals was normalized to the respective 28S ribosomal RNA signals.
Results
In the atria and ventricles, IGF-I mRNA abundance was very low throughout the gestational period studied, whereas IGF-II mRNA levels were higher and readily detectable. In the atria, IGF-I mRNA was very low at 60 days’ gestation and appeared to increase gradually toward term. Abundance of IGF-II mRNA was high at 60 days, increased further until 120 days, and decreased slightly toward term. In contrast, in the ventricles, IGF-I mRNA increased from 60 to 100 days and then declined moderately at term. Levels of IGF-II mRNA in the ventricles were high at 60 days and decreased progressively to low levels at term. No difference in IGF-I or IGF-II mRNA levels was noted between the right and left atria or right and left ventricles.
Conclusion
These results suggest that developmental patterns for IGF-1 and IGF-II gene expression exist in the ovine fetal heart, and the patterns differ between the atria and ventricles. Further, these gestational trends differ from those for atrial natriuretic factor (ANF) found in our previous studies, indicating that expression of the ANF gene in the fetal heart may not be associated with cardiac growth and differentiation.
Similar content being viewed by others
References
Rechler MM, Nissley SP. Insulin-like growth factors. In: Sporn MB, Roberts AB, eds. Peptide growth factors and their receptors. Berlin: Springer-Verlag, 1990:263–346.
Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995;16:3–34.
Lund PK, Moats-Staats BM, Hynes MA. et al. Somatomedin C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem 1986;261:14539–44.
Han VKM, Lund PK, Lee DC, D’Ercole AJ. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: Identification, characterization, and tissue distribution. J Clin Endocrinol Metab 1988;66:422–9.
Mathews LS, Norstedt G, Palmiter RD. Regulation of insulin-like growth factor-I gene expression by growth hormone. Proc Natl Acad Sci USA. 1986;83:9343–7.
Carr JM, Owens JA, Grant PA, Walton PE, Owens PC, Wallace J. Circulating insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and tissue mRNA levels of IGF BP-2 and IGF BP-4 in the ovine fetus. J Endocrinol 1995;145:545–57.
Daughaday WH, Parker KA, Borowsky S, Trivedi B, Kapadia M. Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF-I) radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction. Endocrinology 1982;110:575–81.
Lassarre C, Hardouin S, Daftos F, Forestier F, Frankenne F, Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 1991;29:219–25.
Davenport ML, D’Ercole AJ, Underwood LE. Effect of maternal fasting on fetal growth, serum insulin-like growth factors (IGFs) and tissue IGF messenger ribonucleic acids. Endocrinology 1990;126:2062–7.
Straus DS, Ooi GT, Orlowski CC, Rechler MM. Expression of the genes for insulin-like growth factor 1 (IGF-I), IGF-II and IGF-binding proteins-1 and -2 in fetal rat under conditions of intrauterine growth retardation cauded by maternal fasting. Endocrinology 1991:128:518–25.
Unterman TB, Simmons RA, Glick RP, Ogata E. Circulating levels of insulin, insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding proteins in the small for gestational age fetal rat. Endocrinology 1993;132:327–36.
Han VKM, D’Ercole AJ, Lund PK. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 1987;236:193–7.
Delhanty PJD, Han VKM. The expression of insulin-like growth factor (IGF)-binding protein-2 and IGF-II genes in the tissues of the developing ovine fetus. Endocrinology 1993;132:41–52.
Moses AC, Nissley SP, Short PA, et al. Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum. Proc Natl Acad Sci USA 1980;77:3649–53.
Scott J, Cowell J, Robertson ME, et al. Insulin-like growth factor-II gene expression in Wilms’ tumour and embryonic tissues. Nature 1985;317:260–2.
Guler H-P, Zapf J, Scheiwiller E, Froesch ER. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988;85:4889–93.
Ito H, Hiroe M, Hirata Y, et al. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 1993;87:1715–21.
Reiss K, Cheng W, Kajstura J, Sonnenblick ED, Meggs LG, Anversa P. Fibroblast proliferation during myocardial development in rats is regulated by IGF-I receptors. Am I Physiol 1995:269:H943–51.
Donath MY, Zapf J, Eppenerger-Eberhardt M, Froesch ER, Eppenberger HM. Insulin-like growth factor 1 stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes. Proc Natl Acad Sci USA 1994;91:1686–90.
Sacca L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev 1994;15:555–73.
Johnson DD, Tetzke TA, Cheung CY. Gene expression of atrial natriuretic factor in ovine fetal heart during development. J Soc Gynecol Invest 1994;1:14–8.
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guamdinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–9.
Yang K, Chains JRG, Dales D, Han VKM. Ontogeny of insulin-like growth faccor I (IGF-I) gene expression in selected tissues of fetal sheep (Abstract). Program of the 73rd Annual Meeting of The Endocrine Society. Washington, DC, 1991:142.
Kupfer JM, Rubin SA. Differential regulation of insulin-like growth factor-I by growth hormone and thyroid hormone in the heart of juvenile hypophysectomized rats. J Mol Cell Cardiol 1992;24:631–9.
Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endoc Rev 1989;10:68–91.
Donohue TJ, Dworkin LD, Lango MN, et al. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation 1994;89:799–809.
van Buul-Offers SC, de Haan L, Reijne-Gresnight MG, et al. Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus. J Endocrinol 1995;144:491–302.
D’Ercole AJ, Hill DJ, Strain A, Underwood LE. Tissue and plasma somatomedin-c/insulin-like growth factor I (Sm-C/IGF-I) concentration in the human fetus during the first half of gestation. Pediatr Res 1986;20:253–5.
Han VKM, Hill DJ. Growth factors in fetal growth. In: Thorburn GD, Harding R, eds. Textbook of fetal physiology. Oxford: Oxford Medical Publications, 1994:48–69.
Author information
Authors and Affiliations
Additional information
This work was supported in part by National Institutes of Health grant HD 20299 and a fellowship from the Association of American Gynecological and Obstetrical Society.
Rights and permissions
About this article
Cite this article
Cheung, C.Y., Johnson, D.D. & Reyes, V. Ontogeny of Insulin-Like Growth Factor-I and -II Gene Expression in Ovine Fetal Heart. Reprod. Sci. 3, 309–315 (1996). https://doi.org/10.1016/S1071-5576(96)00038-X
Published:
Issue Date:
DOI: https://doi.org/10.1016/S1071-5576(96)00038-X